Loading clinical trials...
Loading clinical trials...
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete - AS)
Conditions
Locations
56
Canada
Rheumatology Clinic /ID# 54768
Calgary, Alberta, Canada
Associate Clinic /ID# 64274
Calgary, Alberta, Canada
Pont, Cranbrook, BC, CA /ID# 55242
Cranbrook, British Columbia, Canada
Dr. Barbara T. Blumenauer Inc. /ID# 55226
Kamloops, British Columbia, Canada
Hudson, Kamloops, Canada /ID# 54577
Kamloops, British Columbia, Canada
Dr. Maqbool R. Sheriff Inc. /ID# 55247
Nanaimo, British Columbia, Canada
Start Date
June 29, 2011
Primary Completion Date
December 16, 2019
Completion Date
December 16, 2019
Last Updated
December 9, 2020
NCT04402086
NCT07261644
NCT04751396
NCT06707194
NCT06988813
NCT05866614
Lead Sponsor
AbbVie (prior sponsor, Abbott)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions